Abstract
The COVID-19 pandemic poses a psychological challenge, especially for individuals with chronic illnesses. The aim of this study was to investigate associations of cancer with distress, including its interplay with further risk and protective factors. We conducted a representative survey of the German population (N = 2503, including N = 144 with a cancer diagnosis) during the first wave of the pandemic. In multiple linear and logistic regression analyses, we tested associations of cancer with depression and anxiety symptoms and suicidal ideation. We also investigated moderating effects of age, gender, income, living situation, marital status, and loneliness. Individuals with cancer were more likely to report anxiety symptoms (φ = .061), suicidal ideation (φ = .050), and loneliness (φ = .044) than other participants. In regression analyses that controlled for sociodemographic differences, cancer was still associated with anxiety symptoms. We also observed interaction effects, indicating that this relation was especially strong in men with cancer and that cancer survivors with a low income were particularly likely to report anxiety symptoms. The findings demonstrate that cancer survivors are a vulnerable group and that factors of different life domains interact in shaping well-being in the population, necessitating comprehensive risk assessment and support offers during the pandemic and beyond.
Similar content being viewed by others
Introduction
In March 2020 the World Health Organisation declared the spread of SARS-CoV-2, the virus causing coronavirus disease 19 (COVID-19), a pandemic. Since then, many countries around the world have implemented unprecedented prevention measures. The closure of educational institutions and childcare facilities, cuts in the labour market, and far-reaching contact restrictions have led to an ongoing stagnation of public life. Against this background, potential mental health sequelae of the COVID-19 pandemic which could constitute a public health crisis in their own right have come into focus1,2.
Although first empirical evidence has shown little to moderate overall increases in psychological distress3,4,5, the pandemic has also aggravated existing disparities as risk factors for distress during the pandemic corresponded to those observed before its outbreak. For instance, internalizing problems such as depression and anxiety symptoms were more common among those with lower socioeconomic status, women, and individuals who reported being socially isolated4,6,7,8. Furthermore, social isolation and low household income were risk factors for loneliness in a large population study in the UK9.
A particular group at risk for unfavorable outcomes are individuals with pre-existing medical conditions10,11, including common diseases such as cancer. The National Cancer Institute estimates that almost 40% of men and women will receive a cancer diagnosis in their lifetime12. Cancer is now seen as a chronic disease many people can live with for years or even decades due to better diagnostic and treatment options13, but the relations of cancer with mental health are complex: In many studies, cancer patients and long-term survivors14 were more likely than the general population to suffer from anxiety and depression symptoms15,16,17. However, researchers have also warned that especially questionnaire instruments that include items assessing somatic complaints (such as the PHQ-9) could overestimate rates of mental distress in cancer patients/survivors due to their overlap with symptoms of the disease and/or side effects and late effects of its treatment, e.g., tiredness and low energy18,19.
Furthermore, there are considerable differences within cancer patient/survivor samples as the implications of cancer for mental health are also shaped by other risk factors or resources a person has, respectively, such as their financial means, social support, living situation, etc.20,21,22. Along these lines, increased psychological morbidity was no universal finding of large-scale, population-representative investigations from Germany and the United States22,23,24. Researchers have even reported positive psychological outcomes, e.g., under the umbrella term “posttraumatic growth”25,26.
However, there is no dispute that the COVID-19 pandemic implicates a host of new, specific stressors for cancer patients and survivors such as disruptions and/or delays of cancer treatment, bans on companions or visitors, and generally worse access to health-care services27,28. Moreover, research findings indicate that they are more likely than individuals without pre-existing medical conditions to experience a severe course of illness and/or die from COVID-19 if infected29,30. This current threat situation and the increased salience of severe disease and death in the public discourse31 challenge cancer patients’ and survivors’ mental health.
So far, the bulk of mental health research conducted in the context of the COVID-19 pandemic has focused on the general population and health-care workers4,32. In comparison, information about cancer survivors’ well-being is scarce. A large US-based survey, which included 854 individuals with a self-reported cancer diagnosis, found that cancer survivors were more likely to report anxiety and depression symptoms than the rest of the population33. By contrast, in a study conducted at a German university hospital, cancer patients did not report higher levels of distress or anxiety (both COVID-19-related and -unrelated) than matched, healthy controls34. However, their mental health status deteriorated over a 2-week period during the start of the first wave of the pandemic35. These changes were statistically predicted by higher COVID-19-related fear and lower trust in the government. In a sample of 240 Austrian cancer patients surveyed in Spring 2020, female gender was another risk factor for greater distress36. While a longitudinal investigation of 518 cancer survivors in the UK statistically controlled for gender (as a potential confounding factor), it highlighted the detrimental effects of experiencing loneliness during the pandemic as it significantly increased the risk of depression symptoms37. Feelings of social isolation were especially pronounced in older cancer patients and those with lower educational attainment in an Italian survey38.
The present study
The first aim of the present work was to compare cancer survivors’ mental health and feelings of loneliness with the general population using a representative community sample. We hypothesized that more cancer survivors would report clinically relevant symptom burden and loneliness than the general population.
Secondly, we aimed to ascertain the statistical relevance of a cancer diagnosis for anxiety and depression symptoms and suicidal ideation and to examine its interplay with other risk factors such as sociodemographic characteristics. As individual (mental) health is shaped by the intersection and simultaneity of different biological, social, and psychological risk and protective factors, we aimed to expand previous research by also testing moderating effects of e.g., gender, age, and income, with respect to the association of a cancer diagnosis and mental health outcomes. This approach also builds on the cited previous research that has highlighted the ways in which the pandemic affects people differently according to these factors.
We hypothesized that cancer survivors’ psychological vulnerability increased if they were women, lived alone, had a low income, were unmarried, and had a low level of education.
Methods
Survey method
Data was collected between April and June 2020 by the institute USUMA (Unabhängiger Service für Umfragen, Methoden und Analysen; German for: Independent service for surveys, methods and analyses). This period captured the first wave of the COVID-19 pandemic in Germany. Public health measures in place during this time included the closing of school and universities, travel restrictions, the closing of non-essential businesses, and bans of gatherings of more than two people. With respect to the medical domain, outpatient and inpatient diagnostic procedures and treatments were delayed or postponed (by the hospitals burdened with COVID cases and/or by patients afraid of contracting the virus) (e.g.,39,40,41).
The survey was approved by the institutional ethics review board of the University of Leipzig (number 043/20‐ek). All methods were carried out in accordance with the relevant guidelines and regulations. All participants were informed of the study procedures, data collection and anonymization of personal data before providing informed consent. Informed consent was obtained from all participants. If participants were younger than 16 years, consent was also obtained from a parent/legal guardian. Participating households and individuals were chosen using random route procedures and Kish selection42. In-person-interviews were carried out observing hygiene regulations (face masks and physical distance). Sociodemographic information was collected in the form of an interview. After this, participants completed the rest of the questionnaire independently in writing. The interviewer remained present to answer questions of comprehension.
Inclusion criteria were an age of 14 years or older and sufficient German language skills. Participants were individually interviewed at their home by a trained interviewer and completed several questionnaires. In total, 2503 individuals were questioned by trained interviewers (representing 46.5% of the 5418 households addressed). According to information obtained from the Federal Statistical Office, this analysis sample was representative for the German residential population.
Measures
Sociodemographic information comprised participants’ birth date, gender, marital status, living situation, and income. The equivalized income was calculated according to the OECD guideline (Household income/√(people in household)). Monthly income was then categorized as follows: 1 = < 1250€, 2 = 1250–2500€, 3 = > 2500€43.
Anxiety symptoms were assessed using the GAD-2 (capturing nervousness and worrying)44,45. Depression symptoms were assessed using PHQ-2 (capturing depressed mood and anhedonia)46,47. The GAD-2 and PHQ-2 are widely used screening questionnaires using the same response format. Participants are asked to report how often they were bothered by the respective symptom over the course of the last two weeks. Response options are 0 = not at all, 1 = several days, 2 = more than half the days, 3 = nearly every day. The respective sum score thus ranges from 0 to 6. In order to report prevalence rates, we used the previously established cut-off of ≥ 3 for clinically relevant symptom burden. For the GAD-2, Plummer, et al.45 reported a pooled sensitivity of 0.76 and specificity of 0.81. For the PHQ-2, sensitivity was 0.76 and specificity was 0.8748. In the present sample, the GAD-2 (ω = 0.76) and PHQ-2. (ω = 0.72) showed good internal consistency.
We used a single item drawn from the depression module of the Patient Health Questionnaire PHQ-949 to assess suicidal ideation (“Thoughts that you would be better off dead or of hurting yourself in some way”). The response format was the same as for the PHQ-2 and GAD-2 items. In line with previous research50, the item was recoded into a binary variable (0 = not bothered at all, 1 = combining several days, more than half the days, and nearly every day).
Loneliness was assessed with the UCLA 3-item loneliness scale51 capturing the subjective experience of lack of companionship, feeling left out, and isolated from others. Participants respond how often they feel this way on a Likert scale ranging from 0 = “never” to 4 = “very often”. The German version52 is typically scored from 0 to 12 and has previously shown to be measurement invariant with respect to gender and age53. In the present sample, its internal consistency was good (ω = 0.82). In line with previous research54 we used a cut-off of ≥ 5 to differentiate lonely and not lonely participants.
Cancer diagnoses were assessed via self-report (“Have you ever been diagnosed with cancer?”). Response options were “yes” and “no”. Participants were also asked to specify whether they had received a diagnosis during the last 12 months. In line with the definition of the National Cancer Institute55 (i.e., that the time of survival starts at time of diagnosis), we refer to all participants with cancer as cancer survivors within the following text.
Analyses
Data were analyzed using univariate comparisons (independent t tests and χ2-tests, where appropriate). To assess the association of a cancer diagnosis with mental health outcomes, we also calculated two multiple linear regression analyses (of depression and anxiety symptoms) and one multiple logistic regression analysis (of suicidal ideation). Variables tested as statistical predictors comprised sociodemographic variables (age, gender, income, living situation, marital status) and loneliness. All metric predictors used in interaction terms (such as age) were mean-centered before. Age (in years), equivalized income, and loneliness were entered as continuous variables, marital status was coded 0 = not married, 1 = married, education was coded 0 = educational attainment below high school degree, 1 = high school degree and/or further education, living situation was coded 0 = living in a shared household, 1 = living alone. Including the interaction terms, each regression model contained 15 predictors. Therefore, for detecting small effect sizes (f2 = 0.02) with a statistical power level of 0.8, the minimum required sample sized was N = 950. For the logistic regression model of suicidal ideation, there were 235 cases available. Based on established rules of 10 events per variable (EPV), this was a sufficiently large sample size for a logistic regression model including 15 predictors56. Within the models, we checked the Variance Inflation Factor (VIF) for each independent variable. We observed no value above four, indicating no concerning level of multicollinearity57. In the following, regression coefficients and effect sizes are interpreted following Cohen58. P-values refer to two-tailed tests. All analyses were conducted using R version 4.0.3.
Results
Participants
In total, 2,503 individuals took part. Slightly more than half (N = 1329, 53.1%) were women. A cancer diagnosis was reported by 144 participants (5.8% of the sample). Among them were 89 women (61.8%). There were no statistically significant differences regarding mental health outcomes between those who had reported a cancer diagnosis during the last 12 months (N = 37) and those who had received a diagnosis longer ago (N = 107), which is why they were all grouped together for the purpose of the following analyses.
Comparison of participants with and without cancer
Univariate differences between cancer survivors and those without a cancer diagnosis are presented in Table 1. Cancer survivors were significantly older than the rest of the sample (p < 0.001, d = 0.8) and more of them were married (p = 0.004, φ = 0.06). Group comparisons with respect to the prevalence of psychological distress symptoms and loneliness are shown in Fig. 1. The proportions of individuals reporting anxiety symptoms (p = 0.006, φ = 0.061), suicidal ideation (p = 0.018, φ = 0.050), and loneliness (p = 0.035, φ = 0.044) were greater among cancer survivors than among the general population.
Associations of cancer and sociodemographic characteristics with mental health outcomes
We calculated two separate multiple linear regression analyses and one logistic regression analysis to test associations of cancer and sociodemographic characteristics with depression symptoms, anxiety symptoms, and suicidal ideation. Both linear models explained a highly significant proportion of the respective outcome’s variance (adjusted R2 = 0.31 and adjusted R2 = 0.35, respectively).
In the linear regression model of depression symptoms (Table 2), loneliness was the only statistically significant predictor (β = 0.59, p < 0.001). In this model, cancer had no relevant associations with the outcome.
Table 3 shows the linear regression model of anxiety symptoms. Higher levels of anxiety symptoms were related to female gender (β = 0.07, p < 0.001), cancer (β = 0.24, p = 0.003), and loneliness (β = 0.53, p < 0.001). We also observed statistically significant interaction effects in the sense that cancer was a stronger predictor of anxiety symptoms in men compared to women and in individuals with a lower compared to a higher household income. The interaction of cancer and gender is visualized in Fig. 2.
Lastly, within the multiple logistic regression model of suicidal ideation (Table 4), loneliness (OR = 1.35 [95% CI 1.28–1.43], p < 0.001) was related to a higher likelihood of reporting suicidal ideation. This was also the case for higher age (OR = 1.01 [95% CI 1.00–1.02], p = 0.02). However, we found no effects of cancer and no interactions of cancer with other variables within this model.
Discussion
The objective of the present study was to investigate potential differences in mental health outcomes of individuals with cancer and the rest of the general public during the first wave of the COVID-19 pandemic in Germany and to explore the interplay with other risk/protective factors which were previously found to play a relevant role in cancer patients’ and survivors’ mental health and in the emotional well-being of the general population in the context of the pandemic. To this aim, we used data from a representative community sample and calculated both unadjusted comparisons and multiple linear and logistic regression analyses that included several interaction terms.
In our study, individuals with cancer were more likely to report anxiety symptoms, loneliness, and suicidal ideation than other participants. The largest effect size was observed for the group comparison regarding anxiety symptoms (which comprised nervousness and worrying). This is in line with the results of a recent meta-analysis of studies carried out during the pandemic that corroborated higher levels of anxiety symptoms among cancer patients compared to control participants59. A previous representative study conducted in Germany that had assessed cancer patients and survivors as part of a large community cohort before the pandemic had found no overall differences between people affected by cancer and others with respect to current anxiety symptoms22. Similar to the present results, previous research conducted during an early phase of the pandemic had also reported higher rates of loneliness among cancer survivors37 compared to other members of the community in a large, population-based survey. However, in contrast to the already referenced study from the UK37 and a report from the USA33, we did not observe elevated rates of depression symptoms among individuals with cancer. Cancer patients’ and survivors’ levels of depression symptoms have already varied in research reports before the pandemic. As an example, comparatively large proportions of cancer patients fulfilling criteria of clinically relevant depression symptoms60 were contrasted by a longitudinal study within a prospective community cohort that controlled for other biopsychosocial risk factors and found that a cancer diagnosis did not predict depression symptoms (using the PHQ-9) over time61.
Besides anhedonia and depressed mood/hopelessness, the depression symptoms captured by the PHQ-2, the present study investigated suicidal ideation separately. It was more prevalent among cancer survivors. Unfortunately, we could not locate any other empirical research that assessed cancer survivors’ suicidal ideation during the COVID-19 pandemic and compared them to a population sample. This presents a research gap as studies conducted before the pandemic had described cancer survivors’ elevated risk for suicide outcomes including both suicidal thoughts and dangerous behaviors such as suicide attempts62. Given the relevance of social relationships, including feelings of loneliness, for suicidal crises63,64 and the fact that cancer survivors have reported to avoid social contacts during the pandemic due to fear of infection38, we think that health professionals interacting with cancer patients and survivors during and beyond the pandemic should consider assessing suicidality.
Within the regression models that also included sociodemographic characteristics, cancer was an independent risk factor for anxiety symptoms within the whole sample. Furthermore, the study gave insight into risk and protective factors of other domains of life that interacted with cancer. We found that a lower household income increased cancer survivors’ risk of anxiety symptoms. There is previous evidence from an early phase of the pandemic that financial difficulties contributed to US-American gynecologic cancer patients’ worries and anxiety65. In a sample of 394 Australian patients living with hematological cancers, financial concerns (including income losses) were associated with higher levels of psychological distress (operationalized as the Kessler 10-item assessment)66.
We also observed moderating effects of gender. While female gender was associated with higher levels of anxiety within the overall sample, in contrast to our hypothesis, there was an interaction of cancer and gender in the sense that men with cancer were particularly at risk for experiencing higher levels of anxiety. Comparable results were previously reported based on a large, German community cohort22. These findings illustrate that the investigation of gender-dependent associations, e.g., of chronic illness and well-being, is informative (compared to modeling gender as an adjustment variable/solely controlling for it as a potential confounder). As women generally report higher levels of mental distress than men, particularly internalizing symptoms including depression and anxiety symptoms67, such specific risk constellations for men might otherwise not be detected. Possible explanations for the observed stronger relation of cancer and distress in men could be underlying sociocultural differences between men and women that shape a person’s perception, emotions and behavior, such as internalized gender norms: For men, traditionally masculine gender role socialization, respectively hegemonic masculinity emphasizing toughness, physical strength and self-reliance may impede acknowledging and accepting distress68. Previous research has found that male cancer patients are less likely to utilize the psychosocial support offers which are available in the context of German standard care than female cancer patients, even if they are suffering emotionally69. In addition, public health reporting during the COVID-19 pandemic has characterized men as a risk group for worse outcomes if infected with SARS-CoV-270,71, citing both biological and behavior/lifestyle differences between men and women. It is possible that men living with cancer were particularly worried by such news. Along these lines, an Israeli population study underscored the role of perceived susceptibility in shaping emotional reactions to the pandemic threat72.
While the present study cannot give insight whether respective cognitions were relevant for cancer survivors during the pandemic, it showed that biological, social and psychological variables were all involved in participants’ mental health outcomes. In particular, loneliness emerged as an important, potentially modifiable risk factor. Hence, as the pandemic continues and restrictions such as physical distancing measures remain in place, fostering social connectedness – especially in at-risk groups such as cancer survivors – should be a priority of public health interventions. These could, for instance, include “support bubble” solutions (as recommended by the UK Government73) or harness recent advances in digital communication and e-health applications.
Strengths and limitations
The use of a representative, population-based survey has strengths compared to study designs that invite an oversampling of cancer patients and survivors who are distressed (for instance through counseling centers, where one would primarily meet individuals in need of support) and to the use of convenience samples assessed online (which cannot capture the situation of individuals without internet access and with low digital literacy, potentially leading to the systematic exclusion of older and/or especially vulnerable populations in the context of the pandemic74). However, there are also drawbacks to the present approach, such as the relatively small proportions of distressed individuals and the small number of cancer survivors. Future research efforts should survey larger samples of individuals living with cancer. They should also capture potential cancer-specific (such as time since diagnosis, cancer type and stage) and pandemic-specific risk factors (such as experienced treatment delays/disruptions, difficulties obtaining health care, perceived risk of infection, concerns about loved ones, and the like). The lack of such information and the unavailability of a comparison sample assessed before the pandemic (using a comparable methodological approach) present limitations of this study.
Beyond that, given the scarcity of intersectional, in particular gender-sensitive/-specific research in the context of the COVID-19 pandemic e.g.,75, we think that the empirical investigation of interaction effects is a strength of the present study. Like the rest of society, individuals with cancer may be vulnerable to psychological distress or be protected from it, respectively, because of their personal characteristics and their life circumstances. Furthermore, the latter may also be causally related to the disease (see e.g., the financial burden of cancer treatment and care which is often summarized as “financial toxicity”76). Therefore, including information beyond directly disease-related aspects is useful in order to identify particularly vulnerable subgroups. Respective findings can inform targeted prevention and intervention efforts in the community and/or medical settings.
We used only one item (drawn from the PHQ-9) to measure suicidal ideation and screening instruments (PHQ-2 and GAD-2) to assess depression and anxiety symptoms. Given the study design, it was not feasible to include longer questionnaires or clinical interviews although these methods are superior in identifying individuals at risk e.g.,77. With respect to the cancer diagnoses, there was no information about the disease entity/stage/treatment phase. Larger studies that include these aspects are able to ascertain the risk for mental distress by cancer type e.g.,37; this would be especially useful to guide screening and prevention efforts in clinical practice. Lastly, the present study captured only the first wave of the COVID-19 pandemic in Germany. Both levels of distress and specific risk factors for distress might change as the pandemic continues.
Conclusions
Using data from a representative population survey conducted during the COVID-19 pandemic, the present study showed associations of cancer and psychological distress, in particular anxiety symptoms. The findings also indicated that the importance of cancer for a person’s mental health is modified by individual differences and sociodemographic characteristics, such as a person’s gender and financial situation. Within the context of the pandemic, especially economically disadvantaged and male cancer survivors could be in need of more social and/or professional support. Public health measures aimed at containing the spread of the virus should be adapted accordingly to safeguard vulnerable individuals’ mental health.
Data availability
Data is available from the corresponding author upon reasonable request.
References
Holmes, E. A. et al. Multidisciplinary research priorities for the COVID-19 pandemic: A call for action for mental health science. Lancet Psychiatry (2020).
Mari, J. d. J. & Oquendo, M. A. Mental health consequences of COVID-19: The next global pandemic. Trends Psychiatry Psychother. 42, 219–220. (2020).
Prati, G. & Mancini, A. D. The psychological impact of COVID-19 pandemic lockdowns: A review and meta-analysis of longitudinal studies and natural experiments. Psychol. Med. 51, 201–211. https://doi.org/10.1017/s0033291721000015 (2021).
Luo, M., Guo, L., Yu, M., Jiang, W. & Wang, H. The psychological and mental impact of coronavirus disease 2019 (COVID-19) on medical staff and general public—a systematic review and meta-analysis. Psychiatry Res. 291, 113190. https://doi.org/10.1016/j.psychres.2020.113190 (2020).
Ernst, M. et al. Loneliness before and during the COVID-19 pandemic: A systematic review with meta-analysis. (under review).
Tibubos, A. N., Otten, D., Ernst, M. & Beutel, M. E. A systematic review on sex-and gender-sensitive research in public mental health during the first wave of the COVID-19 crisis. Front. Psych. https://doi.org/10.3389/fpsyt.2021.712492 (2021).
Mata, J. et al. Health behaviors and mental health during the COVID-19 pandemic: A longitudinal population-based survey in Germany. Soc. Sci. Med. https://doi.org/10.1016/j.socscimed.2021.114333 (2021).
Beutel, M. E. et al. Mental health and loneliness in the German general population during the COVID-19 pandemic compared to a representative pre-pandemic assessment. Sci. Rep. 11, 14946. https://doi.org/10.1038/s41598-021-94434-8 (2021).
Bu, F., Steptoe, A. & Fancourt, D. Who is lonely in lockdown? Cross-cohort analyses of predictors of loneliness before and during the COVID-19 pandemic. Public Health 186, 31–34. https://doi.org/10.1016/j.puhe.2020.06.036 (2020).
Polenick, C. A. et al. Loneliness during the COVID-19 pandemic among older adults with chronic conditions. J. Appl. Gerontol. 40, 804–813. https://doi.org/10.1177/0733464821996527 (2021).
Wong, S. Y. S. et al. Impact of COVID-19 on loneliness, mental health, and health service utilisation: A prospective cohort study of older adults with multimorbidity in primary care. Br J Gen Pract 70, e817–e824. https://doi.org/10.3399/bjgp20X713021 (2020).
National Cancer Institute. Cancer Statistics. https://www.cancer.gov/about-cancer/understanding/statistics (2021).
Phillips, J. L. & Currow, D. C. Cancer as a chronic disease. Collegian 17, 47–50. https://doi.org/10.1016/j.colegn.2010.04.007 (2010).
Burghardt, J. et al. Prevalence of mental distress among adult survivors of childhood cancer in Germany-compared to the general population. Cancer Med. https://doi.org/10.1002/cam4.1936 (2019).
Mitchell, A. J. et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: A meta-analysis of 94 interview-based studies. Lancet Oncol. 12, 160–174. https://doi.org/10.1016/S1470-2045(11)70002-X (2011).
Linden, W., Vodermaier, A., Mackenzie, R. & Greig, D. Anxiety and depression after cancer diagnosis: Prevalence rates by cancer type, gender, and age. J. Affect. Disord. 141, 343–351. https://doi.org/10.1016/j.jad.2012.03.025 (2012).
Hinz, A. et al. Assessment of depression severity with the PHQ-9 in cancer patients and in the general population. BMC Psychiatry 16, 22. https://doi.org/10.1186/s12888-016-0728-6 (2016).
Grapp, M., Terhoeven, V., Nikendei, C., Friederich, H. C. & Maatouk, I. Screening for depression in cancer patients using the PHQ-9: The accuracy of somatic compared to non-somatic items. J. Affect. Disord. 254, 74–81. https://doi.org/10.1016/j.jad.2019.05.026 (2019).
Jones, S. M. W. et al. A differential item function analysis of somatic symptoms of depression in people with cancer. J. Affect. Disord. 170, 131–137. https://doi.org/10.1016/j.jad.2014.09.002 (2015).
Du, L. et al. Association between social support and suicidal ideation in patients with cancer: A systematic review and meta-analysis. Eur. J. Cancer Care (Engl.). https://doi.org/10.1111/ecc.13382 (2020).
Naughton, M. J. & Weaver, K. E. Physical and mental health among cancer survivors. N. C. Med. J. 75, 283–286. https://doi.org/10.18043/ncm.75.4.283 (2014).
Ernst, M. et al. Linking cancer and mental health in men and women in a representative community sample. J. Psychosom. Res. 124, 109760. https://doi.org/10.1016/j.jpsychores.2019.109760 (2019).
Weaver, K. E. et al. Mental and physical health-related quality of life among U.S. cancer survivors: Population estimates from the 2010 National Health Interview Survey. Cancer Epidemiol. Biomark. Prev. 21, 2108–2117. https://doi.org/10.1158/1055-9965.EPI-12-0740(2012) (2012).
Herschbach, P. The “Well-being paradox” in quality-of-life research. Psychother. Psychosom. Med. Psychol. 52, 141–150. https://doi.org/10.1055/s-2002-24953 (2002).
Tedeschi, R. G. & Calhoun, L. G. Posttraumatic growth: Conceptual foundations and empirical evidence. Psychol. Inq. 15, 1–18. https://doi.org/10.1207/s15327965pli1501_01 (2004).
Stanton, A. L., Bower, J. E. & Low, C. A. Posttraumatic growth after cancer. Handb. Posttraumatic Growth: Res. Pract. 138–175 (2006).
Spicer, J., Chamberlain, C. & Papa, S. Provision of cancer care during the COVID-19 pandemic. Nat. Rev. Clin. Oncol. 17, 329–331. https://doi.org/10.1038/s41571-020-0370-6 (2020).
Al-Quteimat, O. M. & Amer, A. M. The impact of the COVID-19 pandemic on cancer patients. Am. J. Clin. Oncol. 43, 452–455. https://doi.org/10.1097/coc.0000000000000712 (2020).
Kuderer, N. M. et al. Clinical impact of COVID-19 on patients with cancer (CCC19): A cohort study. The Lancet 395, 1907–1918. https://doi.org/10.1016/s0140-6736(20)31187-9 (2020).
Anil, I. et al. The UK Coronavirus Cancer Monitoring Project: Protecting patients with cancer in the era of COVID-19. Lancet Oncol. 21, 622–624. https://doi.org/10.1016/s1470-2045(20)30230-8 (2020).
Menzies, R. E., Neimeyer, R. A. & Menzies, R. G. Death anxiety, loss, and grief in the time of COVID-19. Behav. Chang. 37, 111–115. https://doi.org/10.1017/bec.2020.10 (2020).
Vindegaard, N. & Benros, M. E. COVID-19 pandemic and mental health consequences: Systematic review of the current evidence. Brain Behav. Immun. 89, 531–542. https://doi.org/10.1016/j.bbi.2020.05.048 (2020).
Islam, J. Y., Vidot, D. C. & Camacho-Rivera, M. Evaluating mental health–related symptoms among cancer survivors during the COVID-19 Pandemic: An analysis of the COVID impact survey. JCO Oncol. Pract. https://doi.org/10.1200/op.20.00752 (2021).
Musche, V. et al. COVID-19-related fear and health-related safety behavior in oncological patients. Front. Psychol. 11, 1984. https://doi.org/10.3389/fpsyg.2020.01984 (2020).
Bäuerle, A. et al. Mental health burden of German cancer patients before and after the outbreak of COVID-19: Predictors of mental health impairment. Int. J. Environ. Res. Public Health 18, 2318. https://doi.org/10.3390/ijerph18052318 (2021).
Koinig, K. A. et al. The cancer patient’s perspective of COVID-19-induced distress—A cross-sectional study and a longitudinal comparison of HRQOL assessed before and during the pandemic. Cancer Med. 10, 3928–3937. https://doi.org/10.1002/cam4.3950 (2021).
Gallagher, S., Bennett, K. M. & Roper, L. Loneliness and depression in patients with cancer during COVID-19. J. Psychosoc. Oncol. https://doi.org/10.1080/07347332.2020.1853653 (2020).
Biagioli, V., Albanesi, B., Belloni, S., Piredda, A. & Caruso, R. Living with cancer in the COVID-19 pandemic: An Italian survey on self-isolation at home. Eur. J. Cancer Care. https://doi.org/10.1111/ecc.13385 (2021).
Reichardt, P. et al. Decreased incidence of oncology admissions in 75 Helios Hospitals in Germany during the COVID-19 pandemic. Oncol. Res. Treat. https://doi.org/10.1159/000512935 (2020).
Weisel, K. C. et al. Implications of SARS-CoV-2 infection and COVID-19 crisis on clinical cancer care: Report of the university cancer center hamburg. Oncol. Res. Treat. 43, 307–313. https://doi.org/10.1159/000508272 (2020).
Jacob, L. et al. Impact of the COVID-19 pandemic on cancer diagnoses in general and specialized practices in Germany. Cancers (Basel). https://doi.org/10.3390/cancers13030408 (2021).
Kish, L. A procedure for objective respondent selection within the household. J. Am. Stat. Assoc. 44, 380–387. https://doi.org/10.1080/01621459.1949.10483314 (1949).
OECD. Divided We Stand: Why Inequality Keeps Rising. (OECD Publishing, 2011).
Kroenke, K., Spitzer, R. L., Williams, J. B., Monahan, P. O. & Löwe, B. Anxiety disorders in primary care: Prevalence, impairment, comorbidity, and detection. Ann. Intern. Med. 146, 317–325. https://doi.org/10.7326/0003-4819-146-5-200703060-00004 (2007).
Plummer, F., Manea, L., Trepel, D. & McMillan, D. Screening for anxiety disorders with the GAD-7 and GAD-2: A systematic review and diagnostic metaanalysis. Gen. Hosp. Psychiatry 39, 24–31. https://doi.org/10.1016/j.genhosppsych.2015.11.005 (2016).
Lowe, B., Kroenke, K. & Grafe, K. Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J. Psychosom. Res. 58, 163–171. https://doi.org/10.1016/j.jpsychores.2004.09.006 (2005).
Kroenke, K., Spitzer, R. L. & Williams, J. B. The patient health questionnaire-2: Validity of a two-item depression screener. Med Care 41, 1284–1292. https://doi.org/10.1097/01.MLR.0000093487.78664.3C (2003).
Manea, L. et al. Identifying depression with the PHQ-2: A diagnostic meta-analysis. J. Affect. Disord. 203, 382–395. https://doi.org/10.1016/j.jad.2016.06.003 (2016).
Kroenke, K., Spitzer, R. L. & Williams, J. B. W. The PHQ-9. J. Gen. Intern. Med. 16, 606–613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x (2001).
Louzon, S. A., Bossarte, R., McCarthy, J. F. & Katz, I. R. Does suicidal ideation as measured by the PHQ-9 predict suicide among VA patients?. Psychiatr. Serv. 67, 517–522. https://doi.org/10.1176/appi.ps.201500149 (2016).
Hughes, M. E., Waite, L. J., Hawkley, L. C. & Cacioppo, J. T. A short scale for measuring loneliness in large surveys: Results from two population-based studies. Res. Aging 26, 655–672. https://doi.org/10.1177/0164027504268574 (2004).
Luhmann, M. & Schupp, J. In Psychologische und sozialwissenschaftliche Kurzskalen: standardisierte Erhebungsinstrumente für Wissenschaft und Praxis (eds Elmar Brähler, Markus Zenger, & Christoph J Kemper) (MWV, 2015).
Klein, E. M. et al. Loneliness and its relation to mental health in the general population: Validation and norm values of a brief measure. J. Affect. Disord. Rep. https://doi.org/10.1016/j.jadr.2021.100120 (2021).
Steptoe, A. & Di Gessa, G. Mental health and social interactions of older people with physical disabilities in England during the COVID-19 pandemic: A longitudinal cohort study. Lancet Public Health. https://doi.org/10.1016/s2468-2667(21)00069-4 (2021).
National Cancer Institute. Overall Survival. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/overall-survival (2021).
Peduzzi, P., Concato, J., Kemper, E., Holford, T. R. & Feinstein, A. R. A simulation study of the number of events per variable in logistic regression analysis. J. Clin. Epidemiol. 49, 1373–1379 (1996).
Myers, R. Classical and Modern Regression with Applications. 2 edn (Duxbury, 1990).
Cohen, J. A power primer. Psychol Bull 112, 155–159 (1992).
Ayubi, E., Bashirian, S. & Khazaei, S. Depression and anxiety among patients with cancer during COVID-19 pandemic: A systematic review and meta-analysis. J. Gastrointest. Cancer 52, 499–507. https://doi.org/10.1007/s12029-021-00643-9 (2021).
Hartung, T. J. et al. The risk of being depressed is significantly higher in cancer patients than in the general population: Prevalence and severity of depressive symptoms across major cancer types. Eur. J Cancer (Oxford, England: 1990) 72, 46–53. https://doi.org/10.1016/j.ejca.2016.11.017 (2017).
Tibubos, A. N. et al. Course of depressive symptoms in men and women: Differential effects of social, psychological, behavioral and somatic predictors. Sci. Rep. 9, 18929. https://doi.org/10.1038/s41598-019-55342-0 (2019).
Kolva, E., Hoffecker, L. & Cox-Martin, E. Suicidal ideation in patients with cancer: A systematic review of prevalence, risk factors, intervention and assessment. Palliat. Support Care 18, 206–219. https://doi.org/10.1017/S1478951519000610 (2020).
Ernst, M. et al. Risk factors for suicidal ideation in a large, registry-based sample of adult long-term childhood cancer survivors. J. Affect. Disord. 265, 351–356. https://doi.org/10.1016/j.jad.2020.01.080 (2020).
Rogers, M. L., Joiner, T. E. & Shahar, G. Suicidality in chronic illness: An overview of cognitive-affective and interpersonal factors. J. Clin. Psychol. Med. Settings https://doi.org/10.1007/s10880-020-09749-x (2020).
Chen, Y. S. et al. Financial toxicity, mental health, and gynecologic cancer treatment: The effect of the COVID-19 pandemic among low-income women in New York City. Cancer 127, 2399–2408. https://doi.org/10.1002/cncr.33537 (2021).
Zomerdijk, N. et al. Prevalence and correlates of psychological distress, unmet supportive care needs, and fear of cancer recurrence among haematological cancer patients during the COVID-19 pandemic. Support. Care Cancer https://doi.org/10.1007/s00520-021-06369-5 (2021).
Kuehner, C. Why is depression more common among women than among men?. The Lancet Psychiatry 4, 146–158. https://doi.org/10.1016/s2215-0366(16)30263-2 (2017).
Courtenay, W. H. Constructions of masculinity and their influence on men’s well-being: A theory of gender and health. Soc. Sci. Med. 50, 1385–1401 (2000).
Faller, H. et al. Utilization of professional psychological care in a large German sample of cancer patients. Psychooncology 26, 537–543. https://doi.org/10.1002/pon.4197 (2017).
Gebhard, C., Regitz-Zagrosek, V., Neuhauser, H. K., Morgan, R. & Klein, S. L. Impact of sex and gender on COVID-19 outcomes in Europe. Biol. Sex Differ. 11, 1–13 (2020).
Peckham, H. et al. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat. Commun. https://doi.org/10.1038/s41467-020-19741-6 (2020).
Inbar, L. & Shinan-Altman, S. Emotional reactions and subjective health status during the COVID-19 pandemic in Israel: The mediating role of perceived susceptibility. Psychol. Health Med. 26, 75–84. https://doi.org/10.1080/13548506.2020.1858490 (2021).
UK Department of Health and Social Care. Guidance. Making a support bubble with another household. https://www.gov.uk/guidance/making-a-support-bubble-with-another-household (2021).
Dahlberg, L. Loneliness during the COVID-19 pandemic. Aging Ment Health https://doi.org/10.1080/13607863.2021.1875195 (2021).
Tibubos, A. N., Otten, D., Ernst, M. & Beutel, M. E. A systematic review on sex-and gender-sensitive research in public mental health during the first wave of the COVID-19 crisis. Preprint. https://doi.org/10.31234/osf.io/cbsj6 (2021).
Carrera, P. M., Kantarjian, H. M. & Blinder, V. S. The financial burden and distress of patients with cancer: Understanding and stepping-up action on the financial toxicity of cancer treatment. CA Cancer J. Clin. 68, 153–165 (2018).
Millner, A. J., Lee, M. D. & Nock, M. K. Single-item measurement of suicidal behaviors: Validity and consequences of misclassification. PLoS ONE 10, e0141606. https://doi.org/10.1371/journal.pone.0141606 (2015).
Acknowledgements
We thank all participants and staff involved in data retrieval and management. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Funding
Open Access funding enabled and organized by Projekt DEAL.
Author information
Authors and Affiliations
Contributions
M.E. and M.E.B. designed the study, E.B. contributed to the concept. M.E. planned the analyses. EB led data collection and curation. M.E. conducted the analyses. The first draft was written by ME and edited by MEB and EB. All authors materially participated in the research and have approved the final version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Ernst, M., Beutel, M.E. & Brähler, E. Cancer as a risk factor for distress and its interactions with sociodemographic variables in the context of the first wave of the COVID-19 pandemic in Germany. Sci Rep 12, 2021 (2022). https://doi.org/10.1038/s41598-022-06016-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-022-06016-x
This article is cited by
-
Incidence and risk factors for suicidal ideation in a sample of Chinese patients with mixed cancer types
Supportive Care in Cancer (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.